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ABSTRACT 
The renin angiotensin system (RAS) is a classical endocrine system, regulating body fluid 
balance and blood circulation. Recent research has shown that the system is being also locally 
expressed and active in several organs and tissues. Components of RAS have been discovered 
throughout the gastrointestinal tract and have, in addition, been found in the human 
esophagus. It was hypothesised that RAS could be of interest in relation to gastroesophageal 
reflux disease (GERD), which is a prevalent clinical condition, where gastric content 
backflows into the esophagus and causes troublesome symptoms. The general aim of the 
present thesis was to confirm the presence and further investigate RAS in healthy and reflux 
exposed human esophageal mucosae.  
 
Esophageal biopsies were collected from healthy volunteers and GERD patients. The gene 
activity and protein expression of various RAS components were investigated using RT-PCR, 
western blot, ELISA and immunohistochemistry. The square wave current pulse analysis was 
investigated for its applicability in Ussing chambers for assessing mucosal epithelial 
resistance (Rep), which in turn permits calculation of the epithelial ion current (Iep). 
 
All investigated RAS components were detected and several of these were significantly 
altered in relation to reflux disease. Particular attention was paid to the induced expression of 
the angiotensin II type 2 receptor (AT2R), and to the reduced expression of the angiotensin IV 
(AngIV) receptor (AT4R) in certain areas in the mucosae from patients with erosive reflux 
disease (ERD). Using the validated Ussing chamber method, it was found that biopsies from 
reflux exposed mucosa exhibited lower Rep and higher Iep at baseline. Upon AT2R stimulation 
the healthy individuals responded with increased Iep, while no significant change was 
observed in relation to ERD, despite the higher AT2R expression. The peptide AngIV also 
stimulated the net epithelial current, although the response was small in the mucosae from 
ERD patients. 
 
The thesis demonstrates that a substantial local RAS is present in the human esophageal 
mucosa, and it is likely that also angiotensins other than Angiotensin II are produced. 
Particularly, the AT2R, seems to have reduced response capability in individuals with reflux 
disease. The expressional and functional alterations suggest that RAS might be involved in 
the pathophysiology of GERD. 
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SAMMANFATTNING PÅ SVENSKA 
Matstrupsslemhinnans flerskiktade skivepitel förhindrar att skaldiga ämnen tar sig in i 
vävnaden. Dock kan ett återflöde av magsaft (reflux) reta slemhinnan och orsaka 
gastroesofageal reflux sjukdom (GERD) med symptom så som halsbränna, sura uppstötningar 
och bröstsmärtor. Av okänd anledning verkar GERD-patienter ha en nedsatt förmåga att 
upprätthålla en skyddande epitelial barriär, vilket kan innebära att reflux lättare tränger in i 
vävnaden och orsaka skada (1, 2). Epitelets permeabilitet (genomsläpplighet) kan studeras i 
Ussingkammarförsök genom att mäta vävnadens resistans och jonströmmar. Metoden kan 
vara svårutförd eller inkludera mätvärden från underliggande epiteliala strukturer. Därför är 
behovet av en enkel Ussingkammarmetod med klinisk användbarhet önskvärd. Orsaken till 
nedsatt barriärfunktion i samband med refluxsjukdom är fortfarande okänd, men en studie 
som utförts i vårt laboratorium har indikerat att renin angiotensinsystemet (RAS) påverkar 
epitelets permeabilitet (3) och därmed barriäregenskaper. RAS är ett regulatoriskt 
hormonsystem med väl kända effekter på blodtryck och vätskebalans. Systemet har relativt 
nyligen visat sig finnas lokalt i mag-tarmkanalen (4, 5) och kan vara involverat i processer så 
som inflammation, tillväxt och cellspecialisering (6, 7). RAS är ej väl utforskat i matstrupen 
och har aldrig undersökts i relation till refluxsjukdom, vilket är relevant med tanke på 
systemets kraftfulla regulatoriska egenskaper, dess inblandning i inflammation och dess 
eventuella påverkan på vävnadens genomsläpplighet. Det övergripande syftet med 
avhandlingen är att utreda om RAS är närvarande och aktivt i human matstrupsslemhinna och 
om någon förändring föreligger vid refluxsjukdom.  
 
Hypoteser: 
- att ett lokalt RAS med fler olika angiotensiner finns närvarande och är aktivt i den 
humana matstrupsslemhinnan 
- att RAS är förändrat vid refluxsjukdom 
- att Ussingpuls metoden (UPM) är en användbar metod för att studera epitelets 
genomsläpplighet och att metoden kan särskilja på frisk respektive refluxutsatt slemhinna 
 
UPM utvärderades och användes för att studera vävnadsresistans och jontransporter i epitel 
från matstrupen och jejunum, samt i Caco-2-celler. RAS-komponenters genaktivitet, 
proteinuttryck och proteinlokaliseringen studerades med hjälp av RT-PCR, western blot, 
ELISA och immunohistokemi i både frisk och refluxutsatt matstrupsslemhinna. Effekterna av 
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angiotensin II typ 2 receptorn (AT2R) och angiotensin IV (AngIV) undersöktes med UPM i 
Ussingkammarförsök. 
 
Resultaten visade att Ussingpulsmetoden var en enkel och användbar metod för att studera 
epitelets permeabilitet. De elektriska UPM-parametrarna visade att refluxutsatt 
matstrupsslemhinna hade en lägre vävnadsresistans och förhöjda jonströmmar, vilket i sin tur 
visar på förändringar i epitelets barriäregenskaper. Resultaten demonstrerade även att ett 
omfattande lokalt RAS existerade och var aktivt i den humana matstrupsslemhinnan. Flera av 
systemets komponenter hade ett förändrat uttryck i refluxutsatt slemhinna, vilket tyder på att 
systemet är influerat av eller involverat i GERD. Det förhöjda AT2R-uttrycket i 
refluxslemhinnan skulle kunna innebära en förhöjning av anti-inflammatoriska processer och 
fungera vävnadsskyddande. AT2R och AngIV påverkade epitelets jonströmmar, men vilka 
jonkanaler som påverkades återstår att utreda, men skulle förslagsvis kunna involvera 
jontransporter som inverkar på den intracellulära syraregleringen. Den funktionella betydelsen 
av refluxslemhinnans förändrade AT2R-nivå och aktivitet bör således utredas vidare. 
Sammanfattningsvis visar avhandlingen att ett omfattande renin angiotensinsystem är på plats 
och verksamt i human matstrupsslemhinna och att systemet är förändrat i relation till 
refluxsjukdom. Det är möjligt att stimulering eller inhibering av någon RAS beståndsdel, till 
exempel AT2R, skulle kunna stärka matstrupsslemhinnan att stå emot reflux. Renin 
angiotensinsystemet kan möjligtvis vara ett potentiellt mål för utvecklingen av nya och 
spännande behandlingar mot halsbränna. 
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GEJ  gastroesophageal junction 
GERD   gastroesophageal reflux disease 
GI  gastrointestinal tract 
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IBD  inflammatory bowel disease 
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IHC immunohistochemistry 
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MC  mast cells 
mRNA messenger RNA 
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sphincter relaxation 
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UES   upper esophageal sphincter 
UPM  Ussing pulse method 
WB  western blot
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I. INTRODUCTION 
This thesis explores the renin angiotensin system (RAS) in the human esophageal mucosa and 
its potential role in influencing important epithelial features. RAS is an endocrine system that 
primarily is known for its role in regulating body fluid balance and blood circulation. The 
peptide Angiotensin II (AngII) is regarded as the system’s main effector, responsible for 
exerting “the classical effects”. However, the system contains several angiotensins with 
biological activity that are formed and broken down by various enzymes. Moreover, 
expression of RAS has been discovered locally in different tissues, where it can influence 
various processes.  
 
The system, has for example, been detected throughout the gastrointestinal tract (GI), and it 
has been suggested to participate in regulation of mucosal absorption, secretion, blood flow, 
motor activity and inflammatory signalling. Components of RAS were recently found in the 
human esophagus, where it was shown to modulate muscle contractions and epithelial 
transport processes, which in turn could influence the mucosal barrier properties. The latter is 
of great interest in relation to gastroesophageal reflux disease (GERD), when reflux 
(backflow into the esophagus) of gastric contents causes troublesome symptoms such as 
heartburn and chest pain.  
 
GERD symptoms are very common and affect the daily life of many individuals. The 
pathophysiology behind GERD is complex, involving not only the reflux as such, but also the 
mucosal ability to withstand the refluxate, as well as the central modulation of sensory 
information. Despite that proton pump inhibitors (PPIs), reducing the gastric acid production, 
improve the quality of life for many patients, there are still individuals not benefiting from 
this therapeutic principle and for which no good alternatives exist.  
 
The present thesis project was undertaken in an attempt to connect these unmet clinical needs 
regarding GERD, with the bioscientific possibilities of the presence of RAS in the esophageal 
mucosa. The scientific background to the project and the results from new research are 
summarised and discussed below. 
 11 
II. THE ESOPHAGUS 
Gross anatomy and function 
The esophagus constitutes the first part of the gastrointestinal tract and is a muscular tube 
with the main function of transporting fluids and food boluses from the pharynx into the 
stomach. The organ is approximately 25 cm long and extends through the thoracic cavity and 
enters the abdomen via the diaphragm. Alternating contractions and relaxations of the 
muscles in the esophageal wall create peristaltic waves transporting the food onward. The 
peristalsis is induced upon swallowing, which also results in relaxation of the upper 
esophageal sphincter (UES). When the bolus reaches the distal part of the esophagus the 
lower esophageal sphincter (LES) relaxes (8). LES also plays an important role in preventing 
the backflow of gastric content from the stomach into the esophagus. The primary peristaltic 
wave can be accompanied by secondary contractile waves until the passage is sustained. Both 
the peripheral and the local gastrointestinal enteric nervous system regulate peristalsis and 
sphincter activity. The innervation of the esophagus is primarily through the vagus nerve. The 
proximal part of the esophagus is composed of striated muscles that are regulated by somatic 
nerve fibres arising from the nucleus ambiguous in the brainstem. The mid part of the 
esophagus is composed of both striated and smooth muscles, while the distal part is composed 
of only smooth muscles that are controlled by sympathetic spinal nerves and by 
parasympathetic innervation arising from the dorsal motor nucleus of the vagus (8). 
 
Tissue structure 
The esophagus is subdivided into various tissue layers: mucosa, submucosa, muscularis 
externa and adventitia. The outermost layer is the adventitia that consists of connective tissue 
that covers and attaches the organ. Next to the adventitia is the muscularis externa, which is 
composed of the longitudinal and circular muscles layers that are separated by a ganglion of 
nerve cells, the myenteric plexus. On the inside of the muscular layers is the submucosa, being 
composed of connective tissue, blood vessels, lymph vessels, mucus secreting glands and a 
submucosal nerve plexus (8). 
 
The mucosa is the innermost layer and faces the lumen. The mucosa is divided into 
muscularis mucosae, lamina propria and the stratified epithelium (Figure 1). The muscularis 
mucosae decrease the tension and retail movements to the mucosal surface. The lamina 
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propria extends as papillae in the epithelium and contributes mechanical support with its 
connective tissue and nourishment with its blood vessels. The layer also contains various 
inflammatory cells, lymphatics and nerve fibres (9).  
 
The human esophageal epithelium is squamous and non-keratinized, and can be divided into 
three parts: the germinative stratum basale (basal cell layer), the metabolic active stratum 
spinosum (intermediate or prickle cell layer) and the stratum superficiale (corneum). The 
epithelium is constantly renewed, and as the cylindrical cells in the basal cell layer are 
disconnected from the basal lamina and start to migrate towards lumen they subsequently 
become mature and more flattened. As the cells move from the basal layers they get further 
away from the blood supply, i.e. oxygen and nourishment, and finally degeneration and 
extrusion of dead cells occur at the epithelial surface (9, 10). 
 
 
. 
Figure 1. The esophageal mucosa 
The left panel shows the esophageal epithelium as seen in light microscopy and the right panel is a 
schematic representation of components contributing to the mucosal barrier. 
 
The mucosal barrier 
The esophagus is regularly subjected to mechanic, thermal and chemical stimuli from 
ingested foods and fluids, as well as to backflow of gastric contents. The mucosa is protected 
against potential noxious actions by several features collectively called the mucosal barrier, 
involving the tissue structure, muscle activity, anatomical factors, neural sensory and reflexes, 
blood supply and a mucus layer. The epithelium itself comprises a major part of the mucosal 
protection, but pre- and sub-epithelial factors also contribute.   
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Pre-epithelial barrier 
The lower esophageal sphincter together with the diaphragm creates a pressure barrier 
between the esophagus and stomach that plays an important role for minimizing the reflux 
(backflow) of gastric contents (11), while peristalsis-induced luminal clearance is crucial for 
limiting the duration of contact between noxious substances and the mucosa. A boundary is 
also created by the un-stirred water layer that resides in the lumen in close connection to the 
epithelial cells. The layer originates from esophageal submucosal and salivary glands, and the 
secretion influences moistening, digestion and the mucosal clearance. The submucosal glands 
are located in the connective tissue, with ducts protruding through the squamous epithelium 
and distributing the secretion onto the mucosal surface (10). The secretion contains water, 
mucins, bicarbonate, epidermal growth factors (EGF) and prostaglandins (i.e. PGE2) (12).  
The bicarbonate neutralizes acid in the gastric refluxate and EGF protects and restitutes tissue 
integrity (13). The salivary secretion can increase at intraluminal acidification, probably 
through mediation of pH-sensitive chemoreceptors in the mucosa (12, 13). However, the 
esophageal bicarbonate-mucus layer is not as extensive as the gastric or duodenal layers and 
the esophageal epithelial cells per se do not secrete any bicarbonate (14).  
 
Epithelial barrier 
The stratified esophageal epithelium constitutes an effective barrier, where transepithelial 
transport can occur transcellularly (through cells) or paracellularly (between cells) (Figure 2). 
The hydrophobic epithelial cell membranes are selectively permeable and normally resistant 
to undesirable substances such as acidic gastric contents (14). Although small water-soluble 
molecules and electrolytes may pass paracellularly, the passage is markedly restrained. The 
paracellular permeability is dependent on apical structures between the cells that are formed 
by the tight junctions, adherens junctions and desmosomes, which normally create a rather 
tight barrier in the esophagus (15). The adherens junctional protein E-cadherin has, for 
example, been shown to be important for tight junction assembly and hence for the 
establishment of junctional resistance (1).  
 
The paracellular passage is charge and size selective and sensitive to various factors such as 
digestive contents, cytokines, microorganisms and drugs (16). Refluxed gastric acid, i.e. the 
hydrogen ions, can diffuse into the intercellular spaces and the cells, but the acid is normally 
buffered by bicarbonate, phosphates and proteins or is taken care of by various membranous 
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ion transporters such as the basolateral sodium dependent chloride-bicarbonate exchanger and 
the basolateral sodium-hydrogen ion exchanger (14). Bicarbonate is either produced 
intracellularly by the enzymatic activity of carbonic anhydrases or supplied by the blood. 
 
 
Figure 2. Transcellular and paracellular transport 
Esophageal transepithelial transport processes occurring both transcellularly and paracellularly, 
although the latter is markedly restricted, (17-19). 
 
Sub-epithelial barrier 
The major part of the sub-epithelial defence is constituted by the basement membrane and the 
blood perfusion that delivers various substances such as energy substrates, oxygen and 
bicarbonate and removes carbon dioxide and hydrogen ions. Interestingly, the rate of the 
blood flow can be increased upon acid exposure and injury of the tissue (14). This is 
important to prevent further damage to the underlying tissue layers and also to allow for 
infiltration of phagocytes that can remove injured cells (20). 
 
 15 
Causes of barrier dysfunction 
Impaired integrity can occur when some of the protective mechanisms are lost or the amount 
and frequencies of reflux episodes are abnormal. Anatomical reasons for loss of barrier 
function can be a dysfunctional diaphragm, defective basal LES pressure and/or transient 
lower esophageal sphincter relaxations (TLESR). Sometimes a hiatus hernia is present where 
the stomach protrudes into the thorax (Figure 3). Hiatus hernia can be induced by a 
dysfunctional diaphragm (11) or by prolonged longitudinal muscle contractions that shorten 
the esophagus and lead to relaxation of the LES (8). The flap valve created by the angle 
between the esophagus and the upper part of the stomach, the so-called angle of His (Figure 
3), is also of great importance since the function of the valve diminishes upon widening of the 
angle (11). Interestingly, inflammation as a consequence of acidic reflux has been suggested 
to lower the LES pressure, increase the longitudinal muscle contractions and impair the 
peristalsis (14, 21).  
 
A weakened mucosal barrier can also be due to an insufficient mucus layer or to low content 
of EGF that will increase the risk of epithelial damage. It has been shown that the EGF 
amount is diminished at acid exposure or in inflamed mucosa (13). Other reasons can be that 
the barrier properties of the epithelium are weakened, making it easier for noxious substances 
to diffuse into the tissue (2, 14). 
 
 
Figure 3. The gastroesophageal junction 
A schematic representation of the lower esophageal sphincter (LES), diaphragm and angle of His 
(dotted line depict a wider angle). The right panel shows a Hiatus hernia where the stomach 
protrudes into the thorax. 
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III. GASTROESOPHAGEAL REFLUX DISEASE −  GERD 
An imbalance between the noxious stimuli and the mucosal barrier protection can lead to 
gastroesophageal reflux disease (GERD). GERD is defined in the Montreal definition as “a 
condition that develops when the reflux of stomach contents causes troublesome symptoms 
and/or complications” (22). The pathophysiology behind GERD is complex, involving the 
degree of reflux, the state of the mucosal barrier and the modulation of sensory information in 
the central nervous system. ‘Physiological’ gastroesophageal reflux episodes occur regularly 
in all individuals, especially after a meal when the LES pressure is low (11) and the stomach 
is satiated or during sleep when the regular luminal acid clearance is reduced due to the 
absence of gravity and salivary secretions (12), although the LES pressure is at its highest at 
night (11). 
 
In general, the mucosal barrier should be able to withstand these ‘physiological’ reflux 
episodes, but during conditions with impaired barrier properties the epithelium could be 
challenged and troublesome symptoms may occur. Excessive reflux is another causative 
factor behind GERD. Various pathological conditions, particularly valvular dysfunction of the 
LES, can increase the reflux volume and frequency of the reflux episodes. Obesity is an 
example of a common condition that is strongly associated with GERD. The abdominal fat 
accumulation increases the intra-abdominal pressure and thereby also the risk of backflow of 
gastric contents into the esophagus. Regardless of the reason, an excessive amount of 
refluxate can overcome the esophageal epithelial barrier properties and cause mucosal stress. 
The refluxate contains various substances that have the potential to damage tissue and elicit 
symptoms. These substances include gas, bile salts, pepsin and other digestive enzymes as 
well as gastric acid of which the latter is regarded as the most noxious (14). 
 
GERD symptoms 
Studies indicate that the prevalence of weekly symptoms of GERD is around 20% (23) in the 
Western world and that the disease is more common in Caucasian and Hispanic than in Asian 
and African populations (24, 25). The most common symptoms of GERD are heartburn, 
regurgitation, trouble swallowing and hoarseness. Another indication of reflux can be 
immense chest pain, sometimes mimicking symptoms of coronary heart disease. This is due 
to sensory nerve fibres from the esophagus converging with nerves from the heart (8). 
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Diagnostics 
The diagnosis of GERD is primarily based on symptoms combined with endoscopic 
evaluation of the mucosal appearance and usually also on the response to acid suppression by 
proton pump inhibitors (PPIs). To identify acidic reflux events a 24-48 hour pH-metry can be 
performed immediately above the LES, measuring time with acidic exposure. The exposure 
episodes may or may not be related to symptoms. More sophisticated diagnostic methods can 
be used in unclear cases. The direction, transit time and nature of the refluxed content, e.g. 
liquid, gas, acidity and alkalinity, can be assessed using an impedance-monitoring catheter. 
Refluxed bile can be assessed by the Bilitec® method, where an intra-esophageal catheter 
monitors the light absorption of luminal bile. The intraluminal pressure and hence the LES 
pressure and peristalsis can be measured by manometry, while radiology is useful for 
investigating the appearance of a large hiatus hernia. 
 
Clinical subdivision 
GERD can be differentiated into subgroups based on symptom perception, endoscopic 
evaluation and often some functional examination. The Montreal classification of GERD is 
patient and symptom centered, where patients with typical GERD symptoms are classified 
into esophageal symptoms (with or without esophageal injury) and patients with associated 
symptoms (e.g. cough, laryngitis and asthma) into extra-esophageal symptoms (22). Today, 
however, both the symptoms and endoscopic appearance are often used to classify GERD 
(Figure 4 and 5). Even though the mucosa is endoscopically normal, changes may be 
observed microscopically, such as dilated intercellular spaces (DIS), enlarged papillae length 
(PL) and thicker basal cell layer (BCL) (26, 27). 
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Figure 4. GERD subgroups 
The different GERD subgroups and their common characteristics. 
 
Erosive reflux disease − ERD 
As a result of reflux, the esophageal mucosa can be inflamed and contain mucosal breaks 
(Figure 5). The condition is then referred to as erosive reflux disease (ERD). The diagnosis is 
made endoscopically and the mucosal alterations graded upon appearance according to the 
Los Angeles classification for reflux esophagitis, where the definition of a mucosal break is 
“an area of slough or erythema with a discrete line of demarcation from the adjacent, more 
normal looking mucosa” (28). Symptoms and acidic reflux events are almost always closely 
associated in individuals with ERD (29) and hence symptoms are often improved following 
acid suppressive therapy with PPIs. 
 
 
Figure 5. Endoscopic esophageal mucosal appearance 
The junction between the squamous mucosa and the glandular columnar mucosa in a healthy 
individual (A), a patient with erosive reflux disease (B) and a patient with Barrett’s esophagus (C). The 
arrow in B shows erosion. (The pictures are published in agreement with the owner Anders Edebo) 
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Nonerosive reflux disease − NERD 
Individuals can perceive reflux symptoms (sometimes very severe) even though they do not 
have any mucosal alterations upon endoscopic examination. The condition is then termed 
nonerosive reflux disease (NERD) and may include as many as 70% of GERD patients (30). 
The acid exposure time is abnormal in some individuals, while it is normal in others. 
According to the Rome III criteria, NERD should only be diagnosed if the symptoms are 
associated with gastroesophageal reflux and the mucosa appears normal endoscopically. The 
frequency of successful responses to acid suppressive therapy is lower in patients with NERD 
than ERD (29). This could be due to weakly acidic reflux also being able to elicit symptoms 
that may be a consequence of mucosal hypersensitiveness or to lowered tissue resistance (2, 
14). 
 
Functional heartburn − FH 
Sometimes reflux symptoms are not associated with acidic reflux events and the individuals 
respond poorly to acid suppressive therapy (30). That subgroup is often referred to as 
functional heartburn (FH). The reasons for symptoms unrelated to intra-esophageal acidity are 
not completely known, but may include anatomical and muscular dysfunctions, sensitization 
of neurons, impairment of digestion and reflux of non-acidic substances (29, 30). 
 
Barrett’s esophagus − BE 
If the reflux is severe and chronic the stratified squamous esophageal epithelium can be 
replaced and converted (metaplasia) into columnar lined epithelium of fundic, cardiac or 
specialized intestinal cell types. This condition is termed Barrett’s esophagus and constitutes 
around 2-15% of the GERD patients (31, 32). The condition is considered to be an adaptation 
of the tissue to acid exposure. However, Barrett’s esophagus is associated with a diminutive 
but significant increased risk of 0.1-0.5% per year of developing into esophageal 
adenocarcinoma (EAC), which corresponds to a 10-125 fold higher lifetime risk than in the 
general population (32, 33). 
 
Treatment 
Reflux symptoms can be improved by omitting certain foods and liquids such as fat, spices, 
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coffee, alcohol and tobacco, as well as by weight loss in obese individuals. PPIs are generally 
the first treatment of choice for GERD. The PPIs reduce gastric acid production by inhibiting 
the H+/K+ ATPase pump (proton pump) of the hydrochloric acid producing parietal cells of 
the stomach. Other acid suppressive therapies include histamine receptor antagonists (H2RA) 
that decrease histamine’s stimulating effect on the parietal cells and hence inhibit gastric acid 
secretion. It is also possible to reponate a hiatus hernia and/or to perform a fundoplication, 
which is a surgical procedure where the upper part of the stomach is wrapped around the 
lower part of the esophagus, resulting in strengthening of the LES function and in re-creation 
of the angle of His. Barrett’s esophagus can, in cases with signs of mucosal malignant 
transformation, be treated with esophagectomy, endoscopic resection and/or ablation 
techniques. 
 
The problem 
The prevalence of GERD is high and seems to increase in the Western population. Hence, the 
disease affects the daily life of many people and is an important background factor to the 
growing incidence of EAC (23). The introduction of PPIs some thirty years ago improved the 
quality of life for many GERD patients. Initially, PPI treatment was considered to be the 
solution for all patients with GERD, but it is now evident that as many as 20-50% of patients 
with reflux symptoms are ‘PPI resistant’ (34). For these individuals no good treatment 
alternatives exist, especially not for NERD patients without mucosal breaks or in FH where 
the symptoms are not associated with acidic reflux. Moreover, in cases with confirmed acidic 
reflux, it is not completely understood why the acid causes heartburn and pain. 
 
So, there are still a significant number of individuals for which no potent treatment exists. To 
resolve this therapeutic gap more research is needed to elucidate; the underlying mechanisms 
of GERD; how symptoms are elicited; and why such large differences exist between various 
individuals. It is intuitive that the refluxate as such is important for the occurrence of 
symptoms and/or mucosal disease. Much research has been devoted to the composition of the 
refluxate (acidic, weakly acidic, non-acidic, bile containing, etc.) and to the basis for its 
occurrence (hiatus hernias and TLESR, etc.). This thesis focuses more on the esophageal 
mucosal ability to withstand refluxate and more specifically on the role of the mucosal barrier 
properties.  
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The mucosal barrier and GERD 
The relationship between the barrier properties and the reflux load will determine whether 
symptoms or even mucosal injury will develop. An impaired mucosal barrier may allow 
influx of various refluxed factors (acidic as well as non-acidic), activating sensory nerves that 
reside in the mucosa and underlying tissue layers. A seemingly macroscopically normal 
mucosa may also provoke symptoms (20), particularly in the presence of sensitized spinal 
sensory neurons, thus with lowered activation thresholds (29). Interestingly, it has been 
reported that the epithelium of NERD patients appears to have dilated intercellular spaces due 
to alterations in the apical junction structures. This in turn increases the permeation of 
noxious substances with the potential of eliciting reflux symptoms and influencing proton-
gated ion channels, which might lead to sensitization and neurogenic inflammation (14, 29). If 
considerable amounts of acid reach the intercellular spaces, the normal buffering and 
neutralization capacity can be disturbed due to the activation of basolateral acid-absorbing 
transporters (14). Hence, the regulation of the transepithelial permeability represents an area 
of considerable interest, both with regard to the understanding of GERD pathophysiology and 
also as a potential therapeutic target. Recent research from our laboratory has revealed the 
presence of components of the renin angiotensin system (RAS) in the human esophagus (3, 
35). As RAS is a well-known and potent regulatory system, it may hypothetically influence 
the esophageal barrier dynamics. The present research project was started as an attempt to 
elucidate this possibility.  
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IV. THE RENIN ANGIOTENSIN SYSTEM - RAS 
The renin angiotensin system is an endocrine system that regulates body fluid balance and 
blood circulation. The system can also influence other functions such as inflammation, cell 
growth, proliferation and carcinogenesis and, in addition, have a local and intracellular mode 
of action (7). The system contains various angiotensins of various peptide lengths that are 
formed and broken down by several different enzymes and where the octapeptide Angiotensin 
II (AngII) is regarded as the main effector peptide of the entire system (Figure 6).  
 
 
Figure 6. The renin angiotensin system 
An enlarged view of the renin angiotensin system (RAS) with numerous pathways and effects. 
Abbreviations; ACE: angiotensin-converting enzyme, AP-A, AP-B and AP-M: aminopeptidase A, -B 
and -M, AT1R and AT2R: angiotensin II type 1 and type 2 receptor, AT4R: angiotensin IV receptor, 
CatA, CatD and CatG: Cathepsin A, -D and -G, CMA; mast cells chymase, DAP: dipeptidyl 
aminopeptidases, MasR: mas oncogene receptor, NEP: neprilysin, PCP: prolyl carboxypeptidase, PO: 
prolyl oligopeptidase (an endopeptidase), RPR: renin-prorenin receptor, TO: thimet oligopeptidase (an 
endopeptidase), (4, 5, 7, 36, 37). 
 
The classical RAS – an endocrine system 
Angiotensinogen (AGT), angiotensin I (AngI) and angiotensin II (AngII), together with their 
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formation enzymes renin and angiotensin-converting enzyme (ACE), have been regarded as 
the main components of the system and responsible for the main functions, i.e. regulating 
fluid balance and blood pressure (7). The classical RAS pathway starts by AGT from the liver 
being converted into AngI by the actions of the circulating enzyme renin. Renin is released 
from the juxtaglomerular cells in the kidney in response to low hydrostatic pressure, low 
sodium concentration in the afferent arteriole or increased sympathetic nerve activity. AngI is 
mainly considered to be a pro-hormone, but has some direct vasoconstrictor actions. AngI is 
converted into AngII by ACE, which is found in the vasculature. AngII activates the AngII 
type 1 receptor (AT1R), which has vasoconstrictive effects leading to higher blood pressure, 
and the receptor also promotes aldosterone secretion which in turn causes the kidneys to 
retain water and sodium, resulting in increased blood volume. In addition to the AT1R, AngII 
can bind to the AngII type 2 receptor (AT2R), which often counterbalances the actions of the 
AT1R. 
 
The tissue-located RAS 
A novel view of RAS has emerged from the discovery of numerous peptide-degrading 
enzymes in various tissues. Some of these can constitute alternative AngII-generating 
pathways as well as catalyzing the formation of other ‘angiotensins’ with biological activity. 
Importantly, data are accumulating to suggest that many components of this complex system 
can be expressed locally and thereby regulate the functional state of the tissue in a paracrine 
and intracrine mode of action (7). A brief review of the literature is given below:  
 
AngII generating pathways 
Local AngII generation can occur through various enzymatic processes, e.g. by renin and 
ACE but also through alternative pathways by chymase (CMA), tonin, Cathepsin- A, D 
(CatD) and G (CatG) (Figure 6). 
 
Renin was previously considered to be purely proteolytic and involved in the degradation of 
AGT. Novel data have demonstrated that renin and its proenzyme, prorenin, also exert 
independent proinflammatory and profibrotic signalling via renin-prorenin receptors (RPR). 
The receptors are abundant in the heart, the brain and the placenta, but have also been found 
in the kidney and the liver. RPR seems to recruit prorenin and angiotensinogen, enhancing the 
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catalytic activity of receptor bound renin (7). 
 
CatD can generate AngI from AGT. CatD and renin share an overall structural homology and 
topology with similar active sites. CatD seems to be released after a myocardial infarction and 
is likely to contribute to AngII formation, which in turn has been connected to maladaptive 
remodelling of the myocardium (38, 39). 
 
Chymase (CMA) can, in addition to ACE, enzymatically generate AngII from AngI. CMA is 
released from secretory granules of mast cells (MC) (40). When stored in MC, chymase is 
enzymatically inactive and produces AngII only in pathological situations associated with MC 
degranulation (7). CatG is also expressed by MC (40) as well as by myelomonocytic cells 
(particularly the neutrophils), and can generate AngII directly from AGT (41). Although CatG 
has broader peptidase specificity, it is generally less potent compared with chymase but could 
still be responsible for a considerable part of the AngII production and influence the 
inflammatory processes in certain tissues and species (41, 42). 
 
Other angiotensins 
AngI or AngII can be broken down into smaller peptides: angiotensin 1-9 (Ang1-9), 1-7 
(Ang1-7), 2-8 (AngIII) and 3-8 (AngIV). These peptides were initially thought to have no or 
little biological activity, but have now been shown to bind to specific receptors and exert 
various functions. 
 
Ang1-7 binds to the Mas oncogene receptor (MasR) and is proposed to mediate vasodilatation 
and antithrophic effects, counterbalancing many actions of the AT1R (7). The peptide is e.g. 
generated by the enzymatic activity of ACE, angiotensin-converting enzyme 2 (ACE2) or 
neprilysin/neutral endopeptidase (NEP). ACE2 has high affinity for AngII and is an 
exopeptidase that is structurally similar to ACE but resistant to pharmacological ACE 
inhibitors. 
 
The AngII fragments AngIII and AngIV are also biologically active (37). AngIII is generated 
from AngII by the enzymatic activity of aminopeptidase A (AP-A) or alternatively from AngI 
by the combined actions of AP-A and ACE (43). AngIV is then generated by the degradation 
of AngIII by the actions of aminopeptidase B (AP-B), aminopeptidase M (AP-M; also known 
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as aminopeptidase N and CD13) or dipeptidyl aminopeptidases (DAP). AngIII acts through 
the AT1R and AT2R, and AngIV through the angiotensin IV receptor (AT4R). The AT4R is 
also called insulin-regulated aminopeptidase (IRAP) and oxytocinase (OTase), depending on 
its detection in various tissues and species (37). The best-known AT4R effects are related to 
the central nervous system where it influences e.g. memory retrieval, but it is also known to 
influence vasodilatation, sodium reabsorption, intracellular signalling and insulin-regulated 
glucose uptake (37, 43).  
 
Gastrointestinal RAS 
Numerous RAS components have been discovered throughout the gastrointestinal (GI) tract. 
AGT, renin, ACE, AT1R and AT2R have all been found in the stomach, the small intestine 
and the colon (5). The AngII receptors and ACE2 are greatly expressed at the luminal brush 
border membrane in both the colon and the small intestine (4) and expression of NEP has 
been shown in the human gastric mucosa (44). 
 
Various functions of RAS in the GI tract have been proposed such as absorption and secretion 
of fluid and electrolytes, as well as glucose and amino acid transportation. RAS also seems to 
influence GI blood flow, motility and inflammation, and could be involved in the pathological 
processes of esophageal motility disorders, stomach ulcerations, irritable bowel syndrome 
(IBS), inflammatory bowel disease (IBD) and carcinogenesis (4, 5). 
 
Esophageal RAS – a link to GERD? 
Research in our laboratory has shown that AGT, renin, ACE, AT1R and AT2R are present in 
the human esophageal musculature, where they influence contractions and the high-pressure 
zone at the gastroesophageal junction (GEJ) (35). The RAS components ACE, AT1R and 
AT2R were observed in the vasculature and the two AngII receptors also in the epithelium, 
where they modulated the epithelial ion transport and electrical resistance (3). Because these 
functional modalities have been proposed to reflect mucosal barrier properties, it was 
speculated that the local RAS in the esophageal mucosa might be involved in the epithelial 
barrier impairment observed in GERD. Hence, this hypothetical involvement of RAS in the 
pathophysiology of GERD became the starting point for the research project of this thesis.  
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V. AIMS OF THE THESIS 
There is a lack of knowledge about RAS in the esophagus, especially regarding alternative 
AngII generating pathways and the presence and functions of additional angiotensins, e.g. 
Ang1-7, AngIII and AngIV. The general aim of this thesis was, therefore, to confirm the 
presence and gain new knowledge about the distribution and function of RAS components in 
the healthy esophageal mucosa and to look for aberrations associated with GERD (i.e. ERD). 
The specific aims were: 
 
1. To confirm and further map the presence of RAS in the distal human esophageal 
mucosa of healthy subjects 
2. To investigate the distribution of RAS components in the mucosae from patients 
diagnosed with ERD 
3. To establish an in vitro method for assessment of the epithelial electrical resistance in 
human esophageal mucosa 
4. To investigate in vitro mucosal effects of some RAS components of particular interest  
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VI. METHODOLOGICAL CONSIDERATIONS 
Subjects, tissue and cell culture 
All studies included in the thesis were performed in accordance with the ethical principles 
regarding human experimentations stated in the Declaration of Helsinki. All subjects 
participated voluntarily and were informed verbally and in writing before they signed a 
consent form. The Ethics Committee at the University of Gothenburg and the Regional 
Ethical Review Board in Gothenburg approved the studies.  
 
Tissue handling 
Tissue collection, handling and preparation were performed in a standardized manner, e.g. 
refrigeration, transportation to the laboratory, buffer preparations and tissue stripping. On 
collection, the tissue specimens were immediately placed in fixation medium, Krebs solution 
or liquid nitrogen depending on the subsequent analysis method.  
 
Esophageal tissue 
In paper I, esophageal mucosa was obtained from patients (n=14) undergoing esophagectomy 
for malignancy at the esophagogastric junction. The esophageal specimen was considered to 
be normal for two reasons: it was collected as far as possible from the pathological area and 
normal histological appearance was confirmed. However, it cannot be entirely precluded that 
the tissue, and hence the results, could be influenced by the surgical procedure, the patient’s 
disease history, preoperative medication and radiation. 
 
Endoscopic esophageal biopsies from healthy volunteers and reflux patients were used in 
papers I (healthy n=7 and ERD n=8), II (healthy n=34 and ERD n=28) and III (healthy n=19 
and ERD n=14). The normal biopsies were collected at the distal esophagus, within 1 cm 
from the GEJ, in the 3´o clock circumferential position, where mucosal breaks and histo-
pathological changes are most prevalent (45). The ERD biopsies were collected in and just 
outside the mucosal break area, at the same height. The mucosae of all ERD patients were 
graded according to the Los Angeles classification system for reflux esophagitis. To avoid 
disturbances in the analysis, patients using anti-hypertensives directed towards any RAS 
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component were not included. For two weeks prior to endoscopy, the enrolled patients had to 
abstain from anti-acid medication to resume a symptomatic ERD picture.  
 
One advantage of taking endoscopic biopsies is that human mucosal samples become more 
available both from healthy individuals and from certain patient cohorts. The biopsies were 
taken from the same tissue location (in contrast to the esophagectomy specimens) with the 
same equipment and for the most part also by the same endoscopist, making the results more 
comparative. One factor that could potentially influence the present results was that the mean 
age was higher in the individuals with reflux compared with the healthy controls.  
 
Jejunal tissue 
The jejunal tissue used in paper I was obtained from patients (n=12) undergoing Roux-en-Y 
Gastric Bypass for morbid obesity. It is possible that the specimens were influenced by the 
surgical procedure or that they diverge in some aspect from specimens obtained from 
individuals with normal weight. 
 
Cell culture 
In paper I, Caco-2 cells (passage number 45) were cultured in a medium containing vitamins, 
amino acids and glucose (Dulbecco’s Modified Eagle’s medium supplemented with fetal 
bovine serum, non-essential amino acids and Penicillin-Streptomycin). The cells were first 
cultured in flasks before being seeded onto culture inserts and allowed to grow until confluent 
(cells covering the insert), after which the medium was changed (FBS-free and to the lower 
compartment insulin, transferrin and selenium) to establish cell polarity and structural 
differentiation (46, 47). After that, the cells were cultivated for approximately ten days before 
performing Ussing chamber experiments.  
 
Cell cultures offer the advantage of performing numerous experiments under highly uniform 
conditions without the large variability impacts seen in human specimen settings. Caco-2 cells 
are a human epithelial colorectal adenocarcinoma cell line, but resemble small intestinal 
enterocytes when cultured under specific conditions. However, precautions have to be taken 
regarding e.g. cell clone type, passage time, medium, supplements, cultivation time and cell 
growth supporting material. Mechanisms occurring in Caco-2 cells are, of course, not 
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equivalent to mechanisms occurring in the human small intestine, but can give valuable 
insights into various regulatory steps. In paper I, the cell culture experiments were primarily 
used to validate the Ussing method and not to elucidate physiological mechanisms. 
 
Histology 
Experienced histologists blinded to the experimental protocol examined samples of the tissue 
specimens to confirm normal appearance (I, II and III) or signs of reflux disease (II). The 
tissue specimens were fixed, embedded in paraffin, sections mounted on glass slides and 
examined with white light microscopy. After Ussing chamber experiments, the epithelial 
thickness, edema, cell damage and amount of debris were investigated as well as changes in 
the jejunal epithelial surface area (I). To look for reflux related morphological changes, the 
DIS, PL and BCL thickness were investigated in paper II. 
 
Reverse transcriptase polymerase chain reaction − RT-PCR 
Reverse transcriptase polymerase chain reaction was used in paper II to investigate gene 
transcripts (mRNA) belonging to various RAS components. This method is based on that 
DNA is transcribed into messenger RNA (mRNA) that in turn is translated into proteins. The 
mRNA levels indicate the activity of a gene and hence the probability of production of a 
specific protein. However, mRNA levels do not directly correspond to functional protein 
levels since mRNA: can be rapidly degraded; can be spliced into various variants and; the 
protein can be post-translationally modified. 
 
The RT-PCR process was initiated with the conversion of mRNA into complementary DNA 
(cDNA) using the enzyme reverse transcriptase and specific starter primers. Electrophoresis 
(1.5% agarose gel containing Tris acetate/EDTA and ethidium bromide) of the products was 
performed and compared to molecular weight standard. The cDNA was then replicated during 
thermal cycling, where strands were separated so selective primers could bind and amplify the 
strands with the aid of DNA polymerase. The new strands were in turn used as templates and 
hence the cDNA was exponentially amplified. The samples’ cDNA amounts were compared 
to known standard curves and consequently the initial mRNA levels could be determined. The 
primer sequences and PCR product sizes of the present analyze are shown in paper II, Table I. 
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Western blot −  WB 
The quantitative amounts of the specific proteins were estimated by the antibody-based 
method western blot (WB; immunoblotting), which was used in papers II and III. Tissue 
specimens were first solubilized by sonication with ultrasound energy in buffer containing 
proteinase blockers. Cell debris was removed by centrifugation and the supernatant’s protein 
content was analyzed using the Bradford method (48). Diluted samples were loaded onto a 
porous gel and the proteins were separated according to size by gel electrophoresis in an 
electrical field. The proteins on the gel were transferred (blotted) to a membrane to make the 
proteins detectible to the antibodies. The membrane was then incubated with the specific 
primary antibody and also with a secondary antibody to enhance the signal. The secondary 
antibody was conjugated with alkaline phosphatase that, upon reaction with the reagent CDP-
Star, creates a chemoluminescent light (CDP-Star allow for development for up to 24 hours) 
that in turn can be captured by a camera. Consequently, the specific protein of interest was 
detected and the intensity of the protein bands was analyzed using a software program. 
 
WB is a semi-quantitative analysis, meaning that the protein levels will not be given in 
absolute values but in relation to the intensity of the other analyzed samples. Hence, the 
specific RAS-peptides in the different groups could be graded according to each other. WB is 
based on each antibody’s specificity, which can be verified by analyzing for example a 
positive sample known to contain the protein of interest (e.g. kidney and liver in papers II and 
III) or by pre-incubating the antibody with a control antigen impeding the antibody from 
binding to the target protein. It is also important to compare the detected protein with a 
molecular weight standard so the correct size of the target protein can be confirmed. Another 
aspect to consider is that equal amounts of each sample have to be loaded onto the gel and 
that proteins are completely transferred to the membrane. In papers II and III this was 
controlled for by normalizing the target protein amount to the loading control glyceraldehyde 
3-phosphate dehydrogenase (GAPDH), a so-called house keeping protein required for basic 
cellular functions with a constant expression despite any pathophysiological condition. Also 
the intra assay coefficient of variation for the WB analysis was calculated in the laboratory 
and got a value of 4.6%, which was established by analyzing the same sample in 10 different 
wells on the gel.  
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Enzyme-linked immunosorbent assay −  ELISA 
Enzyme-linked immunosorbent assay (ELISA) is also an antibody-based method and was 
used in paper II to detect the levels of angiotensin II. The tissue specimens were prepared in 
the same way as for WB, and the analysis was performed using a commercial kit. The 
samples were put into separate wells on a plate where the potential AngII could bind to 
immobilized antibodies. The plate was incubated with another antibody labelled with 
acetylcholinesterase that enzymatically reacts with a chromogen, creating a yellow 
compound. The compound was colorimetrically detected, where the intensity of the colour 
corresponds to the amount of AngII in the samples. The absolute amount in each sample was 
determined by comparison with a standard curve with known AngII concentrations.  
 
It is a great advantage that the absolute AngII content can be determined, since this means 
that a sample from one analysis can be compared with a sample from another. However, the 
kits have been developed for use in culture media and blood samples, and not for solid tissue. 
In addition, the used AngII kit also had cross reactivity for AngIII and AngIV (to a lesser 
extend than for AngII). Consequently, it cannot be completely ruled out that some of the 
detected AngII in paper II could in fact have been AngIII or IV. Precautions have to be taken 
also when it comes to the variation in and between the ELISA kits. According to the 
manufacturer the intra and inter assay coefficient of variations are between 2 and 14.5%, 
depending on amount peptide quantified. An intra assay coefficient has also been tested in the 
laboratory and got a value of 3.9%, which was established by analyzing double samples of the 
standard curve.  
 
Immunohistochemistry −  IHC 
Immunohistochemistry was used in papers II and III to find the intraepithelial location of the 
investigated proteins. The tissue specimens were fixed and embedded in paraffin before 
sections were cut and put on glass slides. The paraffin was removed from the tissue and the 
specific antigen was revealed by boiling in citrate buffer, after which incubation with the 
primary antibody was performed. To enhance detection signal, a secondary antibody 
conjugated with an enzyme was used that in turn reacted with a chromogen, resulting in a 
brown colour that was detected with white light microscopy.  
 
As with all antibody-based methods the reliability of the results depends on the specificity of 
 32 
the antibody. As with WB, it can be beneficial to use a positive tissue control section that is 
known to contain the targeted protein. In the present studies, this was only done for new 
antibodies that had never been used in the laboratory before. Another way to check for 
specificity is (as with WB) to use a pre-absorbed control antigen so that the antibody-control 
antigen complex cannot bind any antigen in the tissue. This was not done in the present 
studies because it had already been done previously in the laboratory for some antibodies and 
sometimes no appropriate control peptide exists. A way to preclude unspecificity of the 
secondary antibody is to omit the primary antibody and instead incubate the sections with 
buffer or normal IgG. Such negative control sections were done in both paper II and paper III. 
A limitation of the method is the difficulties to determine the position of the immunoreactivity 
precisely. To increase the resolution and contrast there are other preferable methods such as 
confocal or electron microscopy. However, those techniques were not employed in the present 
studies. 
 
Ussing chamber experiments 
Ussing chamber experiments are attractive because functionality can be assessed concomitant 
with structural studies. In paper I, the epithelial electrical resistance (Rep) was examined by 
square wave current pulse analysis, also called the Ussing pulse method (UPM). In papers II 
and III the UPM was used to characterize endoscopic biopsies from healthy individuals and 
patients with reflux disease (Figure 7). 
 
Figure 7. Ussing chamber and tissue specimens 
An Ussing chamber (A) where the tissue specimen is mounted on pins (B) and clamped between two 
block-halves so that the luminal and “serosal” tissue side face separate reservoirs. Panel C shows a 
jejunal biopsy on an insert that allows direct mounting into the Ussing chamber. Part of the insert 
opening appears in the upper left corner and a scale bar (1 mm) in the upper right corner in C. 
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The Ussing chamber assesses the epithelial electrical characteristics reflecting various 
physiological properties. The epithelial cells actively transport ions to maintain basal cellular 
functions. The Ussing chamber assessed epithelial electrical current (Iep) estimates the net 
transcellular ion transports (see Figure 2), while the electrical epithelial resistance (Rep) 
estimates the paracellular tightness (see Figure 2). The Iep and Rep will cause a charge gradient 
(= potential difference; PD) across the mucosa. The PD in the Ussing chamber can quite 
easily be recorded by using a sensitive voltmeter. The transepithelial ion current can be 
assessed by the short circuit current technique (Scc), applying a known current until the PD 
becomes zero (short circuit current; Isc), after which the resistance can be calculated according 
to Ohm’s law (PD = R x I). The major disadvantage with this approach is that it is not known 
if the Scc-condition affects the endogenous ion transport and if the epithelium is completely 
short-circuited (49, 50) that in turn can give rise to false estimations of Rep. Another approach 
is to instead first assess Rep and then calculate Iep, using instant PD. This principle was chosen 
for the present investigations. The classical way of assessing transepithelial resistance is 
based on Ohm’s law using the PD obtained when applying a known current across the mucosa 
(the current clamp method). One problem with current clamping is that it measures the total 
‘transmural resistance’ (Rtrans) and does not discriminate the resistance of the subepithelial 
tissue (Rsubep) from the epithelial resistance (Rep). The UPM is based on square wave analysis, 
where short lasting current pulses charges the epithelial capacitors, i.e. cells get polarized in 
an electrical field (Figure 8). The subsequent depolarization is dependent exclusively on the 
epithelial resistance, or more correctly, on the epithelial conductance (=1/R). Furthermore, it 
is mainly the paracellular resistance that determines the total resistance of the tissue (51). The 
reason for this is because the transcellular resistance is much higher than the resistance 
existing between cells. As electrical conductivity assumingly reflects the intercellular 
tightness it also reflects the paracellular permeability. However, the latter cannot be taken for 
granted because the electrical conductivity relates to the transport of small-sized ions of the 
tissue fluids and may be unrelated to the passage capacity of larger molecules. Theoretically, 
Rep should be a better estimate of paracellular permeability than Rtrans. This is elucidated in 
further detail in paper I. 
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Figure 8. UPM measurement 
An applied current generates a voltage response and charges the epithelial capacitor, which 
gradually is discharged when the current ends (left panel). The discharge rate depends on the 
epithelial electrical resistance (Rep). The voltage decline is shown in the grey area (left panel) and in 
the right panel. The Rep is assessed from the voltage response (arrow) and the amplitude of the 
applied current. Abbreviations; mV: millivolt, µs: microsecond. 
 
In the present studies, only tissue specimens that possessed satisfying electrical parameters at 
baseline were included. In pilot experimentations, it was observed that esophageal mucosal 
specimens had to have a lumen negative PD >1 mV for resected tissue and >0.3 mV for 
endoscopic biopsies in order to be viable and reactive. Furthermore, in the present studies 
several Ussing chambers were run in parallel and untreated time control preparations were 
always included. The viability of the time control preparation was usually checked at the end 
of the study period by adding the sodium channel blocker amiloride (resulting in a current 
reduction of at least 20%). 
 
Statistics 
Differences in gene activity (II), protein expression (II and III) and dilated intercellular spaces 
(II) were either ordinal data or were not considered to be normally distributed. For that reason 
these parameters were analyzed with the non-parametric methods Kruskal-Wallis and Mann-
Whitney U-test for independent variables, and Wilcoxon’s signed rank test for related 
variables. Due to confirmed normal distribution, large groups or ratio data differences in 
electrical Ussing parameters (I, II and III), probe permeability (I), BCL (II) and PL (II) were 
analyzed parametrically using the Student’s t-test for paired or unpaired values. Associations 
between Rep and Papp (I) were tested by Pearson correlation. Spearman’s correlation was 
considered for non-linear associations. Repeated measurements were taken into consideration, 
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although no adjustment for the risk of mass significance was performed. In paper I, a special 
strategy was developed, where the difference in the electrical Ussing parameters was expected 
to be largest at the end of the time curve. The preceding time point was statistically analyzed 
only if the last time point was significant, and so on. A p-value of ≤0.05 was considered 
significant. Individuals were denoted n and preparations/observations N. 
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VII. RESULTS AND COMMENTS 
1. First aim: to confirm and further map the presence of RAS in the distal human 
esophageal mucosa of healthy subjects 
 
The gene activity, protein expression and location of representative RAS components in the 
human esophageal mucosa were investigated by the use of RT-PCR, WB, ELISA and IHC (II 
and III). Endoscopic biopsies were collected from healthy volunteers at the distal esophagus, 
within 1 cm from the GEJ in the 3 o’clock position. 
 
AngII formation pathways 
Transcription activity and protein expression of the “classical” RAS components: AGT, renin, 
ACE, the AT1R and AT2R were detected in the esophageal mucosa (II), demonstrating that a 
local RAS was present. Interestingly, by using ELISA it was also possible to establish the 
presence of the main effector peptide AngII. The intraepithelial protein locations are 
summarised in Table I and shown in Figure 9. Several of the components were present around 
the papillae, in the blood vessel wall structures and in the basal epithelium, for example AGT, 
renin and ACE. Moreover, several components were evenly distributed across the epithelium, 
thus also in the superficial layers. The latter was true for the AngII receptors, suggesting that 
AngII mediated effects can be exerted even close to the esophageal lumen. The protein 
locations imply that AngII can be locally produced in the mucosa in addition to the infusion 
by the blood. 
 
Moreover, the results indicated that AngII could be generated by alternative pathways, by 
actions of CMA, CatG and CatD. However, CMA and CatG were only detected by IHC 
(Figure 9) and not by WB. This could be due to diverse antibody behaviour at different 
methods, e.g. due to various tissue preservations, buffer solutions and antigen retrievals. 
Strong IHC staining was observed for CMA, which was surprising since the occurrence of 
mast cells are sparse in the esophagus. However, the correctness of this finding is supported 
by that no immunostaining was observed in the negative controls and by previous control of 
the antibody’s specificity for MC in esophageal achalasia specimens (Casselbrant, 
unpublished results). 
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Table I. Location of RAS proteins in the esophageal epithelium 
Protein  Stratum superficiale  Stratum spinosum  Stratum basale  Peripapillary 
ACE  +  +  +  + ves 
AGT  -  +  +  + ves 
AP-A - - - - 
AP-B + cyt + mem, around nuc + + 
AP-M + cyt + mem, nuc + + ves 
AT1R  +  + mem, cyt  + mem, possibly cyt  + 
AT2R  +  + mem, cyt  + mem, cyt  + 
AT4R + cyt + mem, in nuc + + 
CatD  + cyt  + cyt  + cyt  + cyt 
CatG  +  + nuc, cyt  + nuc  + 
CMA  +  +  + cyt, around nuc  + 
MasR  +  + cyt, around nuc  +  + 
NEP  +  + mem, possibly cyt  +  + 
Renin  +  + mem  + nuc  + ves 
+ immunoreactivity  
-  no immunoreactivity  
Abbreviations; ACE: angiotensin-converting enzyme, AGT: angiotensinogen, AP-A, AP-B and AP-M: 
aminopeptidase A, -B and -M, AT1R and AT2R: angiotensin II type 1 and type 2 receptor, AT4R: 
angiotensin IV receptor, CatD and CatG: Cathepsin D and -G, CMA; mast cells chymase, cyt: 
cytosolic, MasR: mas oncogene receptor, mem: membranous, NEP: neprilysin, nuc: nuclear, ves: 
vessels. 
 
Other angiotensins 
The results showed that the esophageal mucosa also probably expresses angiotensins other 
than AngII. The Ang1-7 forming enzyme NEP and the receptor MasR were present, and the 
data also indicated that AngII could be converted to AngIII and AngIV since the formations 
enzymes AP-A, AP-B and AP-M were observed (Figure 9 and WB data in II and III). AP-A 
was not detected by IHC, which could be due to usage of an old secondary antibody or due to 
other technical reasons such as to low primary antibody concentration or to that the antigen 
retrieval was not optimal. Also the AT4R receptor was present, suggesting that AngIV 
mediates biological actions through the receptor in the esophagus. 
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Figure 9. Immunoreactivity of RAS components in the esophageal mucosa 
The panels show immunohistochemical staining of: angiotensinogen (A), renin (B), cathepsin G (C), 
chymase (D), Mas oncogene receptor (E), neprilysin (F), angiotensin II type 1 receptor (G), 
angiotensin II type 2 receptor (H), angiotensin-converting enzyme (I), aminopeptidase B (J), 
aminopeptidase M (K), the angiotensin IV receptor (L) and negative controls (M, N, O). Haematoxylin-
eosin background staining in sections C, D, E and F. 
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1st Conclusion  
All ‘classical’ RAS components were present in the distal esophageal mucosa as were 
enzymes for alternative AngII generating pathways. Expression of the enzymes necessary for 
AngII breakdown was observed, implying that angiotensin 1-7, III and IV also are present in 
the human esophagus. 
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2. Second aim: to investigate the distribution of RAS components in the mucosae from 
patients diagnosed with ERD 
 
RT-PCR, ELISA and WB were used to investigate if the gene activity or protein expression of 
various RAS components were altered in GERD (II and III). 
 
Gene transcription activity 
The gene transcripts of ACE and the AT1R were significantly higher in the mucosal break 
area, as was the ACE levels in the normal mucosa of ERD patients, compared with the 
esophageal mucosa of healthy individuals (Table II) (II). Although that changes in gene 
transcript levels not always correspond to tissue functionality, the observed picture strongly 
supports that the local mucosal RAS was altered in relation to reflux disease. 
 
Table II. Gene transcripts in squamous mucosae  
   Healthy Control   ERD normal epithelium  ERD mucosal break area 
   Median (range)  n  Median (range)  p  n  Median (range)  p  n 
ACE 
 
0 
(0-6.65)  11   8.24 (0-279)  0.034*   10   10.0 (0-56.0)  0.019*   11  
AGT 
 
4.41 
(0-62.9)  11   119.74 (0.05-2888)  0.121   10   30.67 (0.65-450)  0.250   11  
AT1R 
 
0.93 
(0.21-3.56)  11   17.09 (0.02-94.3)  0.260   10   6.67 (0.35-49.0)  0.003**   11  
AT2R 
 
0.47 
(0-5.17)  11   8.35 (0.04-66.1)  0.105   10   4.74 (0.04-21.7)  0.061   11  
Renin 
 
0.24 
(0-2.74)  11   0.95 (0-40.0)  0.193   10   0.07 (0-7.17)  0.921   11  
Abbreviations; ACE: angiotensin-converting enzyme, AGT: angiotensinogen, AT1R and AT2R: 
angiotensin II type 1 and type 2 receptor, respectively. Data are normalised to total RNA and are given as 
median values and range; n = number of individuals. Significant differences from control are indicated 
with asterisks (*=p≤0.05 and ** =p≤0.01)  
 
Protein expression 
Although gene transcription of ACE and the AT1R differed between healthy and reflux-
diseased mucosae the corresponding protein levels were reasonably similar (II). The primary 
explanation to this is that gene transcription and protein expression are processes with 
different time resolution. For example, a gene transcript signal can occur (and disappear) 
before the corresponding protein is detectable in a tissue.  
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In paper II, it was observed that the protein level of the MasR was markedly reduced in the 
mucosal break area (Figure 10 A). Considering that the MasR is ascribed anti-inflammatory 
signalling, it can be speculated that the decreased MasR level can participate partly in the 
inflammatory picture of ERD. 
 
Interestingly, the AT2R protein levels were higher in the normal epithelium of ERD, 
compared with within the mucosal break area, as well as with the mucosa from healthy 
subjects (Figure 10 B) (II). This receptor is described to promote anti-inflammatory processes 
and to be tissue protective (52), so it is possible that the elevated AT2R levels are part of a 
mucosal protective response, counteracting the more hostile luminal environment associated 
with ERD.  
 
The AT4R expression was lower in the mucosal break area than in the normal epithelium of 
ERD patients and a similar trend was observed compared with healthy individuals (p-value 
0.055; Figure 10 C) (III). 
 
 
Figure 10. Protein expression of the MasR, AT2R and AT4  
The MasR (A), AT2R (B) and AT4R (C) in healthy individuals (Healthy) and in endoscopically normal 
epithelium (ERD n.e.) and mucosal break area (ERD m.b.) of ERD patients. The y-axis displays the 
optical density of the protein amounts in relation to the housekeeping protein GAPDH of respective 
sample. Data are expressed as box-and-whiskers plots with median values, interquartile and total 
ranges. Significant differences are indicated with asterisks (*p≤0.05).  
 
2nd Conclusion 
Gene transcription activity and protein expression of various RAS components are altered in 
the mucosa of ERD patients. 
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3. Third aim: to establish an in vitro method for assessment of the epithelial electrical 
resistance in human esophageal mucosa 
 
It was considered of interest to investigate the functional responses of some RAS receptors 
and the Ussing chamber technology was chosen for this investigation since it allows study of 
epithelial properties and pharmacological effects in small sized mucosal specimens. However, 
first the Ussing pulse method (UPM) was tested to see if the transepithelial permeability was 
reflected by the assessed epithelial resistance, which in turn makes optimal Iep calculations 
possible. The applicability of the technique was also examined for very small esophageal 
biopsies. The mucosae were obtained endoscopically, which makes specimens available not 
only from patients but also from healthy individuals, serving as the proper control group. 
 
Can UPM discriminate epithelial resistance from subepithelial resistance?  
Theoretically, analysis of the mucosal response to square wave current pulses (the Ussing 
Pulse Method) can be used to estimate Rep. The UPM was tested on three different types of 
epithelia and in line with the theory the esophageal, jejunal and Caco-2 cell preparations all 
displayed lower Rep than Rtrans, the latter obtained by conventional current clamping (Table 
III). The Rep was highest in the stratified esophageal epithelium (280 Ωxcm2) and lowest in 
the single layer columnar lined jejunal epithelium (∼10 Ωxcm2).  
 
Table III. Electrical parameters in the jejunum, Caco-2 cells and esophagus     _________UPM assessed_________  _____CC assessed____   PD 
(-mV)  Rep (Ω*cm2)  Iep (µA/cm2)  Cep (µF/cm2)  Rtrans (Ω*cm2)  Rsubep (Ω*cm2) 
Jejunum 
(n=8, N=50)  5.6±0.1  9.2±0.6         690±33        14±1.0  72±3               63±3 
Caco-2 
(N=36)  0.6±0.1  143±6           4.7±0.5          19±2  568±16          424±19 
Esophagus 
(n=14, N=42)  5.5±0.4  280±29          39±7.2         1.4±0.4  401±37           121±6 
Abbreviations; CC: current clamping, Cep: epithelial electrical capacitance, Iep: epithelial electrical 
current, n: number of patients, N: number of preparations, PD: potential difference, Rep: epithelial 
electrical resistance, Rsubep: subepithelial electrical resistance, Rtrans: transmural electrical 
resistance, UPM: the Ussing pulse method. Values are given as means±SEM. 
 
The various epithelia were exposed to hypoxia in an attempt to selectively lower the epithelial 
resistance (Figure 11). The Rep of the jejunal preparations and of the Caco-2 cells decreased 
upon hypoxia (Figure 11 A and C) while the resistance from the subepithelial layers was 
relatively constant (I). This observation also supports the theory that the UPM measures the 
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epithelial resistance exclusively.  
 
Does UPM assessed Rep reflect permeability of molecular probes with known size? 
The transepithelial permeation of two probes (FSS, 376-Mw and FD4, 4000-Mw) was 
recorded during the hypoxia experiments in the Ussing chambers. Rep and probe permeability 
had a linear relationship in jejunum and Caco-2 cells, where the probe permeability increased 
with decreased resistance (Figure 11 B and D). This observation implies that Rep not only 
reflect the conductivity of small ions, but also the passage of larger molecules. However, the 
esophageal Rep did not decrease upon hypoxia (Figure 11 E), although the cellular viability 
clearly decreased, as displayed by the marked reduction in PD and Iep (I). In accordance with 
the unchanged resistance, also the permeability of the molecular probes was low. The 
relatively stable esophageal Rep during hypoxia could be due to cell swelling and diminished 
intercellular spaces that would have counteracted a possible resistance decrease. However, 
when the esophageal epithelium was challenged with the bile salt deoxycholic acid (DCA) 
and trypsin, the Rep decreased and the probe permeability increased (Figure 11 F and G), 
which is in line with a previous experiment performed in the rabbit esophagus (53). 
 
 
Figure 11. Challenge of the epithelial integrity  
The epithelial electrical resistance (Rep) in jejunal (A), Caco-2 cells (C) and esophageal (E) 
specimens during oxygenated control situation and during hypoxia. The esophageal epithelium was 
also challenged by 5mM deoxycholic acid (DCA) and 0.04mM trypsin (F). Panel B, D and G 
demonstrate the relationship between Rep and the apparent permeability coefficient (Papp) for 
fluorescein sodium salt (FSS) or fluorescein isothiocyanate-dextran 4000-Mw (FD4). Rep data are 
presented in percentage of baseline and plotted as mean ±SEM. An asterisk denotes a significant 
difference (p≤0.05) between exposure groups and N denotes number of chamber observations. 
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Can UPM be used in small aperture Ussing chambers for endoscopic 
biopsies? 
The UPM validation presented above was performed on surgically resected mucosae or on 
large areas of Caco-2 cell layers. However, to be useful in clinical research, the technique 
should be applicable also on small sized endoscopically acquired mucosal samples. UPM 
applied on esophageal mucosal endoscopic biopsies in mini Using chambers was indeed 
successful, provided that the specimens exhibited an initial lumen negative PD of at least 0.3 
mV (8% of the biopsies were excluded). Furthermore, the mini Ussing preparations 
discriminated between mucosae obtained from healthy individuals and individuals with 
erosive reflux disease (ERD). As shown in Table IV, the ERD epithelium outside the mucosal 
break had almost half the Rep value and more than double the Iep value than the mucosa from 
healthy individuals. In addition, the PD was significantly higher in ERD patients (II). Taken 
together, these results showed that ERD patients had alterations in their epithelial properties, 
indicating events of disease. The lower tissue resistance of ERD patients is in line with a 
previous study (1) and also with the observed tissue alterations in relation to GERD in paper 
II, where the ERD patients had dilated intercellular spaces, which probably results in lower 
epithelial resistance. It was noted that the electrical parameters differed between the 
conventional and the small aperture mini Using chamber, with the PD and Rep being lower in 
the latter (Table III and IV), which e.g. can be due to patient selection or larger impact of 
edge damage effects in the biopsies. 
 
Table IV. Electrical parameters in esophageal biopsies  
Data from paper II PD 
(-mV) 
Rep 
(Ω*cm2) 
Iep 
(µA/cm2) 
 
Healthy controls 
 (n:15, N:57) 
1.1±0.1 66±7 24±3  
ERD normal epithelium 
(n:10, N:33) 
1.7±0.3 * 38±4 * 57±9 *  
Abbreviations; PD: potential difference, Rep: epithelial electrical resistance, Iep: epithelial 
electrical current. Values are given as means±SEM, number of individuals are indicated n and 
preparations N and * denote differences between groups by p≤0.05. 
 
3rd Conclusion 
Square wave current pulse analysis can be used in Ussing chambers for assessment of 
epithelial electrical resistance that in turn reflects transepithelial molecular permeability.  
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4. Fourth aim: to investigate in vitro mucosal effects of some RAS components of 
particular interest  
 
The functionality of the AT2R and AT4R was tested with particular interest because of the 
observed alterations in expression patterns related to ERD. Endoscopic esophageal biopsies 
from healthy volunteers and of ERD patients were mounted in mini Ussing chambers. After 
baseline measurements, either the selective AT2R agonist C21 (II) or the peptide AngIV (III) 
was added to the serosal compartment. 
 
Healthy mucosa 
AT2R stimulation and addition of AngIV resulted in increased ion currents and more lumen 
negative PD, with magnitude of about 8-10% from baseline at dose 1x10-6M  (Figure 12). 
AngIV, which was applied in separate doses, displayed a dose-response relationship. As 
shown in the present investigation the esophageal epithelium expressed the AT4R, which 
likely mediated the observed effects of AngIV. However, to prove such an interaction a 
pharmacological tool interfering with AngIV and the AT4R is needed. Apparently, such 
compounds are becoming available and can be used in future studies (37, 54). The C21 effect 
was truly AT2R mediated since concomitant addition of the AT2R antagonist PD123319 
blocked the Iep and PD increase (II). No changes in the resistance occurred upon AT2R 
stimulation (II) which confirms data from a previous study (3). Now, for the first time, such a 
result was displayed also for AngIV (III). 
 
Figure 12. AT2R and AngIV effects in the healthy mucosa 
Biopsies from healthy volunteers were mounted in Ussing chambers where the AT2R and AngIV 
effects were examined. The left panel shows the changes in the esophageal PD (A) and the right 
panel shows the changes in the Iep (B). Data are mean±SEM of % change from baseline. Significant 
differences from time controls (-) are denoted by p-value: *≤0.05, **≤0.01 and ***≤0.001. 
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ERD mucosa 
In contrast to the healthy mucosa, the Iep did not increase significantly upon AT2R stimulation 
in ERD mucosa, despite higher receptor expression (Figure 13). This implies that the AT2R 
has a reduced capability to increase the net transepithelial current in ERD patients. 
 
When the actions of AngIV were investigated in the normal mucosa of ERD patients a similar 
response was observed as in the mucosa of healthy individuals. Both the PD and Iep increased 
in a dose-dependent manner. However, the increase was not as great as in the healthy mucosa 
(Iep is shown in Figure 13).  
 
 
Figure 13. AT2R and AngIV effects on Iep in healthy individuals and ERD  
Biopsies from healthy volunteers (Healthy) and from endoscopically normal epithelium of ERD 
patients (ERD n.e.) were mounted in Ussing chambers. The % changes from baseline after AT2R 
stimulation (A) and after AngIV addition (B) are shown. Data are expressed as mean±SEM. Significant 
differences from the time controls (-) are denoted by p-value: **≤0.01 and ***≤0.001 
 
4th Conclusion 
Both the AT2R agonist C21 and the peptide AngIV stimulate the net transport of ions in the 
esophageal epithelium and these responses are attenuated in ERD patients. 
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VIII. CONCLUSIONS 
 
1. All ‘classical’ RAS components were present in the distal esophageal mucosa as were 
enzymes for alternative AngII generating pathways. Expression of the enzymes necessary for 
AngII breakdown was observed, implying that angiotensin 1-7, III and IV also are present in 
the human esophagus. 
 
2. Gene transcription activity and protein expression of various RAS components are altered 
in the mucosa of ERD patients. 
 
3. Square wave current pulse analysis can be used in Ussing chambers for assessment of 
epithelial electrical resistance that in turn reflects transepithelial molecular permeability.  
 
4. Both the AT2R agonist C21 and the peptide AngIV stimulate the net transport of ions in the 
esophageal epithelium and these responses are attenuated in ERD patients. 
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IX. GENERAL DISCUSSION 
RAS in the human esophagus 
The main purpose of the thesis was to investigate the expression of the renin angiotensin 
system in the human esophageal mucosa. Several interesting observations were done. First, 
the present data confirm earlier findings of the RAS components: ACE, AT1R, AT2R and 
CatD (3, 55), being present in the esophageal epithelium. Second, for the first time the main 
effector peptide AngII was detected in the mucosa, as were the components AGT, renin, CatG 
and CMA. This, in turn indicates that AngII formation can occur through non-classical 
pathways. Third, the results imply presence of the additional angiotensins: Ang1-7, AngIII 
and AngIV, since their formation enzymes (NEP, AP-A, AP-B and AP-M) and receptors (the 
MasR and the AT4R) were present, in addition to the substrate AngII. Hence, the results 
suggest that AngII can be supplied both by the blood circulation and by local tissue 
production since the component expressions were localized to several tissue compartments, 
i.e. the vessel walls, in close proximity to the papillae, in the entire epithelium and also within 
cells.  
 
Potential involvement of RAS in reflux disease 
The thesis shows that several of the investigated RAS components were altered in relation to 
ERD that in turn implies that the system might be involved in the pathogenesis of the disease. 
It is plausible that RAS can respond to noxious influences with activation or modulation of 
inflammation, proliferation and apoptosis in the esophagus. It is possible that the increased 
gene transcription of ACE and AT1R, as well as the lowered protein expression of the MasR 
(anti-inflammatory), that were observed in relation to ERD in the present investigation, are 
reflecting a pro-inflammatory signal. Although a lot of details remain to be elucidated, the 
potential involvements of RAS in GERD is strongly supported by a recent study, 
demonstrating that AT1R antagonists supported the healing of reflux esophagitis, induced by 
proton pump inhibition (56). It is reasonable to believe that the beneficial effect, not only was 
due to inhibition of the AT1R by a selective AT1R antagonist, but also due to that AngII 
stimulated the unopposed AT2R. Interestingly, in the present investigation, the protein 
expression of the AT2R was increased in the endoscopically normal epithelium of reflux 
patients. This receptor is described to promote anti-inflammatory processes and to be tissue 
protective (6, 52). Thus, it is very appealing to speculate that the present up-regulation of the 
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AT2R in ERD might be a mucosa protective adaptation to reflux attacks. 
 
The Ussing pulse method - UPM 
The Ussing pulse method, using square wave current pulse analysis, was evaluated for 
assessment of the epithelial electrical resistance and current, both being factors reflecting the 
mucosal barrier properties. 
 
The present validation showed that the UPM allowed measurements of the epithelial 
resistance (i.e. reciprocal to conductance), omitting the resistance from the subepithelial 
compartment. The esophageal epithelium exhibited higher Rep and lower Papp compared with 
the jejunal and Caco-2 cell monolayers. The results also indicated that simultaneous probe 
measurements could be omitted in the future since UPM assessed Rep reflected the molecular 
transepithelial permeability. However, unlike the columnar intestinal epithelia, the squamous 
esophageal epithelium was in the basal state quite impermeable to medium-sized molecular 
probes. Only after challenging the mucosal viability with noxious substances, the Rep was 
reduced and the molecular probe permeability was increased substantially. Still, as Rep, per 
definition, is reciprocal to paracellular electrical conductance (see Methodological 
considerations) the esophageal epithelial resistance appears to be a good estimate of the 
passage capacity of small-sized ions, for example hydrogen ions, making it very useful also 
during conditions with intact epithelial integrity. 
 
Furthermore, the UPM can be valuable when examining small biopsies acquired during 
clinical routine endoscopies. In the present study, the esophageal ERD biopsies exhibited 
lower Rep and higher Iep at baseline than the biopsies obtained from healthy individuals. This 
confirms pathophysiological changes and epithelial disease in ERD, as has previously been 
suggested (1). 
 
The present electrical baseline parameters deviated from values obtained in other Ussing 
chamber studies. Besides patient cohorts, therapy and surgical procedures, this is likely due to 
different Ussing chamber techniques. The UPM technique is based on the assumption of a 
capacitor and resistor coupled in parallel and has not been used as frequent as e.g. the short 
circuit current technique (Scc). The estimations are certainly dependent on whether the 
parameters are assessed (UPM: PD and Rep, Scc: PD and Isc) or calculated (UPM: Iep, Scc: 
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Rtrans). It is likely that Rep is more sensitive than Rtrans (57) and there are indications that ion 
currents are underestimated at Scc conditions (49, 50). The present results showed that the 
electrical parameters also diverged between the conventional and the mini Ussing chambers. 
These deviations are likely due to the relative sizes of the investigated tissue specimens 
(conventional chamber: 0.29 cm2, mini chamber: 0.018 cm2), since the impact of edge 
damages increases with smaller area due to a larger edge to surface ratio. In theory, the PD is 
independent of the area but the mounting process damages the tissue and consequently the PD 
is lowered (17, 58, 59). 
 
In summary, despite some principle differences, compared with for example Scc based 
measurements and the well known edge effect of small aperture Ussing setups, the UPM 
application was considered to be a rather user-friendly technique, having a time resolution 
suitable for investigating esophageal endoscopic biopsies.  
 
Actions of RAS in the esophagus 
Based on its widespread expression, it appears very likely that RAS exerts regulatory actions 
in the human esophagus. This concept was strengthened by the present results, and by 
previously reported observations of AngII being a potent stimulator of esophageal muscle 
contractions in vivo (35), and of its influence on the epithelial electrical parameters in vitro 
(3). The present results confirm that the AT2R influences Iep but not Rep in healthy mucosa 
(3), which in the present study was shown to be the case also for AngIV. However, the ERD 
mucosa did not respond with increased Iep upon AT2R stimulation, despite higher receptor 
levels as shown by WB. The ERD mucosa responded with increased Iep upon AngIV addition. 
However, the response was small compared to healthy mucosa. These results imply that the 
capability of the AT2R and possibly also the AT4R is altered in relation to reflux disease. The 
mechanisms behind these alterations remains to be elucidated but could be due to functional 
defects, to faster endogenous peptide cleavage or to receptor internalization. An alternative 
explanation could be that the already elevated Iep at baseline in the ERD preparations reduced 
the capability to further increase the net transepithelial current. The baseline shift could in 
turn be due to endogenous AngII, stimulating the receptors or to other, so far unknown, 
stimulatory mechanisms. 
 
The AT2R is reported to influence duodenal HCO3- secretion in the rat (60) and to block 
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Na+/H+ exchangers in the mouse (61). The AT4R is described to affect the intracellular Na+ 
and Ca2+ concentrations and also the activity of the Na+/K+ ATPase pump in the kidney 
proximal tubule cells (62, 63). Na+/H+ exchangers and Cl-/HCO3- transporters are of particular 
interest in the esophagus, where sodium absorption is the main ion transport event occurring. 
The consequent electrochemical gradient is used to regulate the intracellular pH, by absorbing 
HCO3- or extruding H+ from the cell cytosole. Increased H+ extrusion protects the tissue from 
cellular damage, but can in the long-term lead to cytosolic alkalinization and luminal 
acidification (64). It has been shown that GERD patients have induced expression of the 
basolateral Na+/H+ exchanger NHE-1 and also that the Na+/K+ ATPase pumps have increased 
activity (64). These GERD associated alterations could be an explanation to the present 
observed increase of the basal net currents in ERD. It is also possible that RAS components, 
e.g. the AT2R and AT4R, influence the activity of the described channels and, hence, affect 
the intracellular acid regulation. This remains to be elucidated, but it is apparent that tuned ion 
transport processes are vital for optimising the barrier properties in order to protect the 
mucosa from reflux attacks.  
 
Plasticity of RAS 
RAS is a potent regulatory system, exerting effects on the intracellular, tissue, organ and 
systemic level (7, 65). The plasticity and complexity of RAS is spectacular with various 
pathways, with compensatory and feedback component production and with various 
components having counteracting effects (6, 7). In addition, several of the angiotensins have 
affinity for various receptors and, some components can act as both receptors and enzymes 
(e.g. the AT4R and ACE) (4, 7, 37). Other important determinants for activity are the rate of 
delivery or formation, as well as elimination of angiotensins, that in turn are dependent on the 
actual expression pattern of the RAS associated enzymes. 
 
The detection of RAS components does not necessarily mean that RAS is active in a tissue. 
RAS enzymes can e.g. act on other substrates than angiotensins and RAS receptors might 
bind other ligands. One well-known example is ACE that, in addition to the formation of 
AngII, also participates in the kinin-kallikrein system with the inactivation of bradykinin. 
Hence, it is possible that components included in RAS are involved in “RAS independent 
processes” such as submucosal gland secretion (e.g. CMA), hormone and neurotransmitter 
degradation (e.g. ACE, NEP, AP-M and AT4R), peptide signalling (e.g. NEP), inflammation 
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(e.g. CMA and CatG) as well as cellular differentiation, proliferation and carcinogenesis (e.g. 
CMA CatD, AP-M) (7, 37). However, the result of the present thesis, with presence of an 
extensive RAS, including the key mediator AngII, and with observed in vitro actions of RAS 
receptors, strongly indicate that the system exerts physiological effects in the human 
esophageal mucosa.  
 
Future perspectives 
GERD is a disease affecting the daily life of many people and the prevalence is increasing. 
The introduction of PPIs improved the quality of life for many patients, but the treatment fails 
to completely reduce symptoms in some cases and, thus, there are still individuals acquiring 
insufficient treatment. The pathophysiology behind GERD is complex, involving various 
mechanisms such as reflux amount, muscle and sphincter tension, processing of sensory 
information and state of the mucosal barrier. This thesis has focused on the renin angiotensin 
system and its role in GERD and particularly the system’s potential impact on the epithelial 
barrier properties. The studies were undertaken in an attempt to connect the bioscientific 
possibilities with the still unmet clinical needs regarding GERD. Examining endoscopic 
biopsies in mini Ussing chambers with the user-friendly UPM may facilitate future studies 
concerning GI and esophageal diseases. Exploration of RAS in the esophagus has the 
potential to reveal new diagnostic and therapeutic targets. The present results revealed that 
many RAS components, not least the receptors, are regulated and act differently in the 
mucosa of reflux patients. Many agonists/antagonists interfering with RAS are already 
commercially available and more are under development. It is possible that some of the RAS 
components, for example the AT2R, could be an interesting pharmaceutical target for treating 
GERD, e.g. by reducing inflammation or by strengthening the esophageal mucosal barrier 
properties and hence improve the ability to withstand a noxious refluxate. 
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